Clinical Trials
All Clinical Trials - Page 34 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02557620Phase 1Completed
Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly
Semaglutide
- NCT02542137Phase 2Withdrawn
Abscopal Effect for Metastatic Small Cell Lung Cancer
Thymosin-Alpha-1
- NCT02535988Phase 2Withdrawn
Abscopal Effect for Metastatic Colorectal Cancer
Thymosin-Alpha-1
- NCT02677311N/ATerminated
GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient
Gonadorelin
- NCT02794402Phase 2Completed
Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
Exenatide
- NCT02455076Phase 4Completed
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
Exenatide
- NCT02917057N/ACompleted
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
Exenatide
- NCT02690987EARLY_Phase 1Unknown
Gut Hormones in Obesity, Nicotine and Alcohol Dependence
Exenatide
- NCT02473809Phase 4Completed
The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
Liraglutide
- NCT02660047Phase 4Completed
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
Liraglutide
- NCT02058940Phase 4Completed
Intravenous Exenatide in Patients With Acute Brain Injury
Exenatide
- NCT02541734Phase 1/Phase 2Completed
Effect of Gelofusine on GLP1-receptor Imaging
Exenatide
- NCT02467920Phase 4Completed
Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
Exenatide
- NCT02406690N/ACompleted
Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects
Gonadorelin
- NCT02492763Phase 2Terminated
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Liraglutide
- NCT02420262Phase 3Completed
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT02505334Phase 3Completed
A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
Liraglutide
- NCT02231658Phase 1Terminated
Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
Liraglutide
- NCT02225366Phase 1/Phase 2Completed
Intratumoral Injections of LL37 for Melanoma
Ll-37
- NCT02196831N/ACompleted
Tesamorelin Effects on Liver Fat and Histology in HIV
Tesamorelin
- NCT02507128N/AUnknown
Effects of Glucagon Like Peptide-1 on No-reflow
Liraglutide
- NCT02490176N/AUnknown
Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
Liraglutide
- NCT02584582Phase 2/Phase 3Unknown
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
Liraglutide
- NCT02909933Phase 4Completed
Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
Liraglutide
- NCT02987348N/ACompleted
Clinical Outcomes of Exenatide Versus Basal Insulin
Exenatide
- NCT02430480Phase 2Completed
Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
Gonadorelin
- NCT02483767Phase 3Completed
Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer
Gonadorelin
- NCT02388529Phase 1Withdrawn
A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure
Elamipretide
- NCT02436447Phase 1Completed
A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function
Elamipretide
- NCT00749853Phase 3Suspended
Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
Gonadorelin
- NCT02423824Phase 3Completed
Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
Liraglutide
- NCT02503943Phase 4Unknown
Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
Liraglutide
- NCT02472717Phase 2Withdrawn
Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
Liraglutide
- NCT02432976Phase 2/Phase 3Completed
Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
Exenatide
- NCT03059719Phase 1Completed
Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT02431689N/ACompleted
Delayed Embryo Transfer in Poor Responders
Gonadorelin
- NCT02545738Phase 4Completed
Antiproteinuric Effects of Liraglutide Treatment
Liraglutide
- NCT03189953Phase 1/Phase 2Completed
68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH
Exenatide
- NCT02969590Phase 4Completed
Regulation of Cervical Mucus Secretion
Gonadorelin
- NCT02255266N/ACompleted
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
Liraglutide
- NCT02385630N/ACompleted
Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer
Ghrp-6
- NCT03541395N/ACompleted
Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
Gonadorelin
- NCT02303730Phase 4Completed
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
Exenatide
- NCT03095833N/ATerminated
Food Intake Decisions
Ghrp-6
- NCT02368964N/ACompleted
IVF Treatment in Women With Immature Oocytes in Previous Cycle
Gonadorelin
- NCT02765399Phase 4Completed
The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
Liraglutide
- NCT02367014Phase 1/Phase 2Completed
Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy
Elamipretide
- NCT02369796Phase 2Terminated
A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism
Kisspeptin
- NCT02361905Phase 4Unknown
Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
Gonadorelin
- NCT02269072N/AWithdrawn
Testosterone Regulation of the Natriuretic Peptide System
Gonadorelin